Published in Pigment Cell Melanoma Res on April 26, 2008
PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. Cancer Cell (2013) 3.71
Peroxisome proliferator activated receptor α ligands as anticancer drugs targeting mitochondrial metabolism. Curr Pharm Biotechnol (2013) 0.95
Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth. Cell Death Differ (2010) 0.92
Silencing of GPNMB by siRNA inhibits the formation of melanosomes in melanocytes in a MITF-independent fashion. PLoS One (2012) 0.86
Nuclear hormone receptor functions in keratinocyte and melanocyte homeostasis, epidermal carcinogenesis and melanomagenesis. FEBS Lett (2013) 0.78
Modulation of PPARγ provides new insights in a stress induced premature senescence model. PLoS One (2014) 0.75
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature (2005) 15.28
Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science (1997) 8.99
Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol (1999) 7.66
Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly. Cell (2005) 7.62
Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol (2004) 5.49
The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat Genet (2005) 4.70
Melanocytes and the microphthalmia transcription factor network. Annu Rev Genet (2004) 3.78
Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell (2002) 3.72
Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res (2004) 3.64
microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev (1994) 3.44
Reprogramming metastatic tumour cells with embryonic microenvironments. Nat Rev Cancer (2007) 3.17
Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev (2006) 2.87
Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. Cancer Cell (2004) 2.80
Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression. Nature (2005) 2.44
PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev (1997) 2.29
Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator. Mol Cell Biol (1994) 2.24
Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat Res (2000) 2.15
The WNT/Beta-catenin pathway in melanoma. Front Biosci (2006) 2.09
Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor. J Cell Biol (2002) 2.00
Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin. Mol Cell Biol (2006) 1.95
MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A. J Cell Biol (2004) 1.89
Induction of melanocyte-specific microphthalmia-associated transcription factor by Wnt-3a. J Biol Chem (2000) 1.80
PPARalpha governs glycerol metabolism. J Clin Invest (2004) 1.79
Vasculogenic mimicry. APMIS (2004) 1.76
Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J Clin Invest (1995) 1.74
Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt. Clin Cancer Res (2006) 1.49
Melanoma, a tumor based on a mutant stem cell? J Invest Dermatol (2006) 1.48
The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism. FASEB J (2001) 1.45
The microphthalmia-associated transcription factor Mitf interacts with beta-catenin to determine target gene expression. Mol Cell Biol (2006) 1.31
Brachyury-related transcription factor Tbx2 and repression of the melanocyte-specific TRP-1 promoter. Mol Cell Biol (1998) 1.28
Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner. Pigment Cell Res (2005) 1.28
Vitamin D-3 receptor as a target for breast cancer prevention. J Nutr (2003) 1.28
Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells. Endocrinology (2006) 1.23
Snail-regulated genes in malignant melanoma. Melanoma Res (2005) 1.17
Retinoids in cancer chemoprevention. Curr Cancer Drug Targets (2004) 1.16
The neural crest cell lineage problem: neuropoiesis? Neuron (1989) 1.16
Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias. Mol Cancer Ther (2004) 1.15
Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. Clin Cancer Res (2002) 1.14
Microphthalmia-associated transcription factor in the Wnt signaling pathway. Pigment Cell Res (2003) 1.12
New assays for the tyrosine hydroxylase and dopa oxidase activities of tyrosinase. Eur J Biochem (1991) 1.11
Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging. Curr Opin Lipidol (1999) 1.10
Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma. Oncogene (2006) 1.08
A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma. Br J Cancer (2003) 1.08
Inhibition of melanoma metastases by fenofibrate. Arch Dermatol Res (2004) 1.08
Peroxisome proliferator-activated receptor modulators as potential chemopreventive agents. Mol Cancer Ther (2002) 1.08
Cellular and molecular consequences of peroxisome proliferator-activated receptor-gamma activation in ovarian cancer cells. Neoplasia (2006) 1.04
Malignant melanoma. Arch Pathol Lab Med (2001) 1.04
Molecular regulation of melanocyte senescence. Pigment Cell Res (2002) 1.02
Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines. Acta Pharmacol Sin (2005) 1.01
Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation. Neoplasia (2005) 1.01
Uveal melanoma cell staining for CD34 and assessment of tumor vascularity. Invest Ophthalmol Vis Sci (2002) 0.96
New strategies in the treatment of acute myelogenous leukemia (AML): in vitro culture of aml cells--the present use in experimental studies and the possible importance for future therapeutic approaches. Stem Cells (2001) 0.94
Ciglitazone-induced cellular anti-proliferation increases p27kip1 protein levels through both increased transcriptional activity and inhibition of proteasome degradation. Cell Signal (2004) 0.91
Retinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptor. Mol Cell Biol (1996) 0.89
Tumour re-differentiation effect of retinoic acid: a novel therapeutic approach for advanced thyroid cancer. Curr Pharm Des (2005) 0.88
Pigmentation in melanomas: changes manifesting underlying oncogenic and metabolic activities. Oncol Res (2002) 0.88
The effect of PPARgamma ligands on the proliferation and apoptosis of human melanoma cells. Melanoma Res (2003) 0.86
Impaired homologous recombination DNA repair and enhanced sensitivity to DNA damage in prostate cancer cells exposed to anchorage-independence. Oncogene (2005) 0.86
Expression and function of peroxisome proliferator-activated receptors in human melanocytes. Br J Dermatol (2004) 0.84
Human melanoma cell lines show little relationship between expression of pigmentation genes and pigmentary behaviour in vitro. Pigment Cell Res (1998) 0.80
Differentiation of human malignant melanoma cells that escape apoptosis after treatment with 9-nitrocamptothecin in vitro. Neoplasia (1999) 0.77
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health. Oncotarget (2011) 3.43
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging (Albany NY) (2011) 2.72
Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice. Oncogene (2004) 1.96
Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt. Clin Cancer Res (2006) 1.49
Cancer cell detection in tissue sections using AFM. Arch Biochem Biophys (2011) 1.32
Medulloblastoma: from molecular pathology to therapy. Clin Cancer Res (2008) 1.30
Inhibition of p66ShcA longevity gene rescues podocytes from HIV-1-induced oxidative stress and apoptosis. J Biol Chem (2009) 1.24
Fenofibrate-induced nuclear translocation of FoxO3A triggers Bim-mediated apoptosis in glioblastoma cells in vitro. Cell Cycle (2012) 1.23
Activated IGF-1R inhibits hyperglycemia-induced DNA damage and promotes DNA repair by homologous recombination. Am J Physiol Renal Physiol (2005) 1.21
Role of the insulin-like growth factor I/insulin receptor substrate 1 axis in Rad51 trafficking and DNA repair by homologous recombination. Mol Cell Biol (2003) 1.21
Insulin-like growth factor I receptor activity in human medulloblastomas. Clin Cancer Res (2002) 1.15
ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARalpha -mediated inhibition of glioma cell motility in vitro. Mol Cancer (2010) 1.15
Integrins mediate adhesion of medulloblastoma cells to tenascin and activate pathways associated with survival and proliferation. Lab Invest (2008) 1.10
T-antigen of the human polyomavirus JC attenuates faithful DNA repair by forcing nuclear interaction between IRS-1 and Rad51. J Cell Physiol (2006) 1.08
Activation of PPARalpha inhibits IGF-I-mediated growth and survival responses in medulloblastoma cell lines. Int J Cancer (2008) 1.08
Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiol Aging (2006) 1.08
Inhibition of melanoma metastases by fenofibrate. Arch Dermatol Res (2004) 1.08
Advances in targeting signal transduction pathways. Oncotarget (2012) 1.06
Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways. Int J Cancer (2013) 1.04
Human polyomaviruses and brain tumors. Brain Res Brain Res Rev (2005) 1.04
Effects of JC virus infection on anti-apoptotic protein survivin in progressive multifocal leukoencephalopathy. Am J Pathol (2007) 1.02
Insulin receptor substrate 1 translocation to the nucleus by the human JC virus T-antigen. J Biol Chem (2002) 1.00
Inhibition of wild-type p66ShcA in mesangial cells prevents glycooxidant-dependent FOXO3a regulation and promotes the survival phenotype. Am J Physiol Renal Physiol (2006) 0.97
Insulin-like growth factor I receptor signaling system in JC virus T antigen-induced primitive neuroectodermal tumors--medulloblastomas. J Neurovirol (2002) 0.96
p73 Interacts with human immunodeficiency virus type 1 Tat in astrocytic cells and prevents its acetylation on lysine 28. Mol Cell Biol (2005) 0.96
Anticancer Properties of PPARalpha-Effects on Cellular Metabolism and Inflammation. PPAR Res (2008) 0.96
Targeting the cancer initiating cell: the ultimate target for cancer therapy. Curr Pharm Des (2012) 0.96
Peroxisome proliferator activated receptor α ligands as anticancer drugs targeting mitochondrial metabolism. Curr Pharm Biotechnol (2013) 0.95
Mechanisms of singlet-oxygen and superoxide-ion generation by porphyrins and bacteriochlorins and their implications in photodynamic therapy. Chemistry (2010) 0.93
Neuroprotective effects of IGF-I against TNFalpha-induced neuronal damage in HIV-associated dementia. Virology (2003) 0.93
Fenofibrate attenuates contact-stimulated cell motility and gap junctional coupling in DU-145 human prostate cancer cell populations. Oncol Rep (2011) 0.93
HIV-1 Tat increases cell survival in response to cisplatin by stimulating Rad51 gene expression. Oncogene (2004) 0.92
Insulin-like growth factor-I receptor - a potential therapeutic target in medulloblastomas. Expert Opin Ther Targets (2002) 0.90
Verteporfin, photofrin II, and merocyanine 540 as PDT photosensitizers against melanoma cells. Biochem Biophys Res Commun (2006) 0.90
T-antigen of human polyomavirus JC cooperates withIGF-IR signaling system in cerebellar tumors of the childhood-medulloblastomas. Anticancer Res (2003) 0.89
IRS-1-Rad51 nuclear interaction sensitizes JCV T-antigen positive medulloblastoma cells to genotoxic treatment. Int J Cancer (2006) 0.88
HIV-1 Tat inhibits NGF-induced Egr-1 transcriptional activity and consequent p35 expression in neural cells. J Cell Physiol (2008) 0.88
Biodistribution and photodynamic efficacy of a water-soluble, stable, halogenated bacteriochlorin against melanoma. ChemMedChem (2011) 0.87
Evidence for the involvement of Puralpha in response to DNA replication stress. Cancer Biol Ther (2007) 0.87
The new face of nucleolin in human melanoma. Cancer Immunol Immunother (2009) 0.87
Involvement of alpha1beta1 integrin in insulin-like growth factor-1-mediated protection of PC12 neuronal processes from tumor necrosis factor-alpha-induced injury. J Neurosci Res (2006) 0.86
The mechanism of contribution of integrin linked kinase (ILK) to epithelial-mesenchymal transition (EMT). Adv Enzyme Regul (2010) 0.86
The effect of PPARgamma ligands on the proliferation and apoptosis of human melanoma cells. Melanoma Res (2003) 0.86
Impaired homologous recombination DNA repair and enhanced sensitivity to DNA damage in prostate cancer cells exposed to anchorage-independence. Oncogene (2005) 0.86
The structure of the oligosaccharides of alpha3beta1 integrin from human ureter epithelium (HCV29) cell line. Acta Biochim Pol (2002) 0.85
HIV-Tat promotes cellular proliferation and inhibits NGF-induced differentiation through mechanisms involving Id1 regulation. Oncogene (2004) 0.84
Crystal structure of a covalent intermediate of endogenous human arylsulfatase A. J Inorg Biochem (2003) 0.84
Cytochalasin D, LY294002 and olomoucine synergize in promoting death of melanoma cells through activation of caspase-3 and apoptosis. Melanoma Res (2010) 0.84
Insulin-like growth factor-I-forkhead box O transcription factor 3a counteracts high glucose/tumor necrosis factor-α-mediated neuronal damage: implications for human immunodeficiency virus encephalitis. J Neurosci Res (2010) 0.83
Cross talk between growth factors and viral and cellular factors alters neuronal signaling pathways: implication for HIV-associated dementia. Brain Res Brain Res Rev (2005) 0.83
Different glycosylation of cadherins from human bladder non-malignant and cancer cell lines. Cancer Cell Int (2002) 0.83
Expression of VEGF, VEGF-C and VEGFR-2 in in situ and invasive SCC of cervix. Front Biosci (Elite Ed) (2010) 0.83
Interaction between serine phosphorylated IRS-1 and beta1-integrin affects the stability of neuronal processes. J Neurosci Res (2007) 0.83
IGF-IR in neuroprotection and brain tumors. Front Biosci (Landmark Ed) (2009) 0.83
Dysregulation of NGF-signaling and Egr-1 expression by Tat in neuronal cell culture. J Cell Physiol (2006) 0.83
Curcumin does not switch melanin synthesis towards pheomelanin in B16F10 cells. Arch Dermatol Res (2014) 0.83
Estrogen receptor beta-mediated nuclear interaction between IRS-1 and Rad51 inhibits homologous recombination directed DNA repair in medulloblastoma. J Cell Physiol (2009) 0.82
The expression and activity of cystathionine-γ-lyase and 3-mercaptopyruvate sulfurtransferase in human neoplastic cell lines. Amino Acids (2010) 0.82
Targeting the cancer initiating cell: the Achilles' heel of cancer. Adv Enzyme Regul (2010) 0.82
Photocytotoxicity of platinum(IV)-chloride surface modified TiO2 irradiated with visible light against murine macrophages. J Photochem Photobiol B (2008) 0.81
Null mutations at the p66 and bradykinin 2 receptor loci induce divergent phenotypes in the diabetic kidney. Am J Physiol Renal Physiol (2012) 0.81
The structure of the oligosaccharides of N-cadherin from human melanoma cell lines. Glycoconj J (2004) 0.80
Effects of kinetin riboside on proliferation and proapoptotic activities in human normal and cancer cell lines. J Cell Biochem (2011) 0.80
Adhesion properties of human bladder cell lines with extracellular matrix components: the role of integrins and glycosylation. Acta Biochim Pol (2002) 0.80
The chemotactic activity of beta-carotene in endothelial cell progenitors and human umbilical vein endothelial cells: A microarray analysis. Exp Clin Cardiol (2006) 0.80
Transplantable melanomas in gerbils (Meriones unguiculatus). II: melanogenesis. Exp Dermatol (2003) 0.80
Polycyclic aromatic hydrocarbons-induced ROS accumulation enhances mutagenic potential of T-antigen from human polyomavirus JC. J Cell Physiol (2013) 0.79
Characterization of N-cadherin unbinding properties in non-malignant (HCV29) and malignant (T24) bladder cells. J Mol Recognit (2011) 0.79
Carbohydrate moieties of N-cadherin from human melanoma cell lines. Acta Biochim Pol (2002) 0.79
NO-dependent phototoxicity of Roussin's black salt against cancer cells. Nitric Oxide (2004) 0.79
Cross-talk between T-Ag presence and pRb family and p53/p73 signaling in mouse and human medulloblastoma. J Cell Biochem (2010) 0.79
Insulin-like growth factor-I produced by seminal vesicles: relationship to intraepithelial basal cell hyperplasia in the prostate. Clin Cancer Res (2007) 0.79
Inhibition of ERβ induces resistance to cisplatin by enhancing Rad51-mediated DNA repair in human medulloblastoma cell lines. PLoS One (2012) 0.79
Determinants of the activity and substrate recognition of breast cancer resistance protein (ABCG2). Drug Metab Rev (2014) 0.78
Photodynamic activity of platinum(IV) chloride surface-modified TiO2 irradiated with visible light. Free Radic Biol Med (2007) 0.78
Re: Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratories by Rollison et al. (published online 21 October 2004). Int J Cancer (2005) 0.78
Angiogenesis in Balb/c mice under beta-carotene supplementation in diet. Genes Nutr (2009) 0.78
Different effect of beta-carotene on proliferation of prostate cancer cells. Biochim Biophys Acta (2005) 0.77
Nitrosylhemoglobin in photodynamically stressed human tumors growing in nude mice. Nitric Oxide (2013) 0.77
Expression of fucosyltransferases contributes to melanoma invasive phenotype. Med Chem (2007) 0.77
Sclerotia of the acellular (true) slime mould Fuligo septica as a model to study melanization and anabiosis. Cell Mol Biol Lett (2007) 0.77
Specific detection of glycans on a plasma membrane of living cells with atomic force microscopy. Chem Biol (2006) 0.77
[Effect of conjugated linoleic acid isomers on proliferation of mammary cancer cells]. Rocz Panstw Zakl Hig (2009) 0.77
Pulmonary metastases of the A549-derived lung adenocarcinoma tumors growing in nude mice. A multiple case study. Acta Biochim Pol (2013) 0.77
Zinc-pheophorbide a-highly efficient low-cost photosensitizer against human adenocarcinoma in cellular and animal models. Photodiagnosis Photodyn Ther (2013) 0.77
Effects of point mutations on protein structure are nonexponentially distributed. Proteins (2012) 0.76
A comparative study of glycoproteomes in androgen-sensitive and -independent prostate cancer cell lines. Mol Cell Biochem (2013) 0.76
Splenic melanosis during normal murine C57BL/6 hair cycle and after chemotherapy. Acta Biochim Pol (2013) 0.76
Platelets augment respiratory burst in neutrophils activated by selected species of gram-positive or gram-negative bacteria. Folia Histochem Cytobiol (2008) 0.76
Interplay between the retinoblastoma related pRb2/p130 and E2F-4 and -5 in relation to JCV-TAg. J Cell Physiol (2007) 0.76
Involvement of IRS-1 interaction with ADAM10 in the regulation of neurite extension. J Cell Physiol (2014) 0.76
Tipifarnib and tanespimycin show synergic proapoptotic activity in U937 cells. J Cancer Res Clin Oncol (2011) 0.75
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy. Curr Pharm Des (2016) 0.75
The microarray expression analysis identifies BAX as a mediator of beta-carotene effects on apoptosis. Nutr Cancer (2005) 0.75